Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02029443 |
|---|---|
| Brief Title: | ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia |
| First Submitted : | January 6, 2014 |
| First Submitted that Met QC Criteria : | January 6, 2014 |
| First Posted : | January 8, 2014 (Estimate) |
| Results First Submitted : | June 27, 2022 |
| Results First Submitted that Met QC Criteria : | August 17, 2022 |
| Results First Posted : | September 10, 2022 |
| Last Update Submitted that Met QC Criteria : | April 22, 2024 |
| Last Update Posted : | April 24, 2024 |